Drug-coated Balloons Market Report on the Untapped Growth Opportunities in the Industry

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Drug-coated Balloons Market- by Product (Drug-Coated Balloons for Peripheral Artery Disease, Drug-Coated Balloons for Coronary Artery Disease and Drug-Coated Balloons for Other Indications), End User (Hospitals, Cardiac Catherization Labs and Ambulatory Surgical Centers), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

The Drug-coated Balloons Market Size is valued at 594.0 Million in 2022 and is predicted to reach 1301.8 Million by the year 2031 at a 9.2 % CAGR during the forecast period for 2023-2031.

Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1099

Drug-coated balloons are semi-compliant angioplasty balloons treated with cytotoxic chemotherapeutic agents (DCB). Commercial settings are increasingly using balloons coated with paclitaxel. Drug-coated balloons are a novel approach developed in recent years to solve the shortcomings of drug-coated stents and are expected to be effective under challenging subgroups. The number of drug-coated balloons discovered for coronary and peripheral purposes was recently calculated through preclinical and clinical investigations, with promising results.

The global market for drug-coated balloons is anticipated to be driven by increasing technological advancement and interest in minimally invasive surgery. The prevalence of peripheral and coronary artery problems is on the rise globally, a significant factor affecting the market. The vast patient base in developing countries, the fast-expanding geriatric population with cardiovascular diseases, and cumulative investments in R&D for treating peripheral and coronary artery problems are additional significant factors driving the market expansion. The global market for drug-coated balloons is expected to expand gradually due to the high cost of procedures and materials and the stringent regulatory restrictions.

North America is anticipated to contribute to the Drug-coated Balloons market. A sizable disease population's prevalence and improved treatment access are the fundamental causes of the high market share. The North American market is predicted to grow profitably during the projection period due to new product approvals, expanded indication approvals for commercially existing DCBs, the availability of a plethora of clinical evidence, and the approval of new products. In addition, the Asia Pacific Drug-coated Balloons market is expected to register significant growth due to the aging population in the area, the desire for higher-quality healthcare, and the rise in the prevalence of cardiovascular diseases. China's aging population is contributing to an increase in cardiovascular ailments and disorders.

Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1099

Major market players operating in the Drug-coated Balloons market include
Medtronic, BD, Koninklijke Philips, B. Braun Melsungen, BIOTRONIK, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, Cardionovum, Concept Medical, ENDOCOR, Hexacath, iVascular SLU, M.A. Med Alliance, Minvasys, Orchestra BioMed, QT Vascular, RD Global-Invamed, Surmodics, Terumo, Welling, and Other prominent players.

Recent collaborations and agreements in the market:
• In May 2022, FDA approval for the investigational device exemption was given to MedAlliance's SELUTION SLR Drug-eluting Balloon. The novel sirolimus-eluting balloon known as the SELUTION SLR (Sustained Limus Release) gives a regulated and sustained drug release, much like a drug-eluting stent.
• In June 2020, iVascular SLU introduced Essential Pro, a ground-breaking coronary artery drug-coated balloon, on a global scale (DCB). The Essential Pro DCB improves on its predecessor in several ways, including more excellent safety and quick deflation times owing to an extension of the inflating channel and the availability of two different shaft options.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1099

Market Segments
Global Drug-coated Balloons Market, by Product, 2022-2028 (Value US$ Mn)
• Drug-Coated Balloons for Peripheral Artery Disease
• Drug-Coated Balloons for Coronary Artery Disease
• Drug-Coated Balloons for Other Indications
Global Drug-coated Balloons Market, by End User, 2022-2028 (Value US$ Mn)
• Hospitals
• Cardiac Catheterization Labs
• Ambulatory Surgical Centers
Global Drug-coated Balloons Market, by Region, 2022-2028 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• U.S.
• Canada
Europe Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
> To receive a comprehensive analysis of the prospects for the global Drug-coated Balloons market
> To receive an industry overview and future trends of the Drug-coated Balloons market
> To analyze the Drug-coated Balloons market drivers and challenges
> To get information on the Drug-coated Balloons market value (US$ Mn) forecast to 2028
> Significant investments, mergers & acquisitions in the Drug-coated Balloons market industry

For More Information: https://www.insightaceanalytic.com/report/global-drug-coated-balloons-market-/1099

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Site Visit: www.insightaceanalytic.com
Email: info@insightaceanalytic.com

Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

This release was published on openPR.